Biogen Inc (NASDAQ:BIIB)

301.85
Delayed Data
As of Dec 01
 -3.17 / -1.04%
Today’s Change
187.16
Today|||52-Week Range
311.88
+25.81%
Year-to-Date
Repligen (RGEN) Up 4.3% Since Last Earnings Report: Can It Continue?
Dec 01 / Zacks.com - Paid Partner Content
Biogen (BIIB) Down on Report of Death in Alzheimer's Study
Nov 29 / Zacks.com - Paid Partner Content
Lilly's (LLY) Donanemab Betters Biogen's Alzheimer's Drug
Dec 01 / Zacks.com - Paid Partner Content
CinCor (CINC) Tanks Due to Dismal Data on Hypertension Drug
Nov 29 / Zacks.com - Paid Partner Content
Biogen's (BIIB) Lecanemab Shows Benefit but With Side Effects
Nov 30 / Zacks.com - Paid Partner Content
Gilead (GILD), RCUS Announce Positive Data From NSCLC Study
Nov 29 / Zacks.com - Paid Partner Content
Gilead (GILD) Gets EC Approval for Biktarvy Label Expansion
Nov 30 / Zacks.com - Paid Partner Content
Spectrum's (SPPI) NDA for NSCLC Candidate Gets CRL From FDA
Nov 28 / Zacks.com - Paid Partner Content
Steven Cohen Loads Up on Workday, Dumps Coca-Cola
Nov 29 / GuruFocus News - Paid Partner Content
2 Stocks Near 52-Week Highs That Could Climb Higher
Nov 28 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close305.02
Today’s open305.97
Day’s range299.17 - 306.23
Volume87,435
Average volume (3 months)1,427,476
Market cap$43.9B
Data as of 4:00pm ET, 12/01/2022

Growth & Valuation

Earnings growth (last year)-58.03%
Earnings growth (this year)-11.15%
Earnings growth (next 5 years)-2.09%
Revenue growth (last year)-15.81%
P/E ratio15.4
Price/Sales3.45
Price/Book4.12

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+2.78+1.27%
----
BMRNBiomarin Pharmaceuti...+2.07+2.05%
MRNAModerna Inc+5.57+3.17%
Data as of 4:00pm ET, 12/01/2022

Financials

Next reporting dateFebruary 2, 2023
EPS forecast (this quarter)$3.48
Annual revenue (last year)$10.4B
Annual profit (last year)$1.6B
Net profit margin14.96%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts